China Startup CirCode Gets Clearance for Trial of Circular RNA Therapy
Cir‑Code Bio‑med, a Chinese biotech focused on circular RNA medicines, has secured an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration to commence its first human trial. The therapy targets a rare genetic disorder using a self‑splicing circular RNA construct that can produce therapeutic proteins more durably than linear mRNA. This clearance marks the inaugural FDA‑approved study of a circular RNA drug candidate. The trial will evaluate safety, dosing, and expression kinetics in a small patient cohort.
Clostridia From Preterm Infants Harness HMOs to Protect Gut
A Nature Microbiology study reveals that specific Clostridia strains isolated from preterm infants can efficiently metabolize human milk oligosaccharides (HMOs). The bacterial conversion produces short‑chain fatty acids and other bioactive metabolites that suppress pathogenic bacteria and enhance intestinal barrier gene...
Biotech Building ‘Molecular Glues’ AI Platform Raises £3.6m
London‑based Ternary Therapeutics announced a £3.6 million seed round to fund its AI‑driven platform for designing molecular glues, a class of drugs that can bind previously "undruggable" proteins. The startup, founded in 2024, merges machine learning, physics‑based molecular modelling and rapid...
STAT+: Structure Therapeutics Reports Significant Weight Loss From Mid-Stage GLP-1 Pill
Structure Therapeutics announced that its daily oral GLP‑1 obesity pill produced an average 16% body‑weight reduction versus placebo after 44 weeks in a Phase 2 trial. The result outperforms Eli Lilly’s orforglipron, which showed about 11% loss over 72 weeks, and rivals...
Structure Therapeutics Reports More Phase 2 Data for Oral GLP-1
Structure Therapeutics released Phase 2 data for its oral GLP‑1 agonist, positioning the candidate as a next‑generation alternative to injectable therapies from Eli Lilly and Novo Nordisk. The trial demonstrated a mean 30% reduction in HbA1c and 70% of participants achieving target...
The Peptide Boom Is Getting Out of Hand
The Atlantic outlines a surge in off‑label and experimental peptide use, noting that Vyleesi—approved for women’s hypoactive sexual desire disorder—is being bought by men through “research use only” listings and online pharmacies. Compounding pharmacies and telehealth firms now market customized...
After Novartis Pact, Macrocycle Shop Unnatural Products Gets $45M Series B
Santa Cruz‑based Unnatural Products secured a $45 million Series B round to accelerate its macrocycle drug platform. The financing follows a newly announced partnership with Novartis that will grant the pharma giant early access to the company’s pipeline and a co‑development option...
Biophytis and LynxKite Expand Alliance to Boost AI-Driven Drug Discovery
Biophytis has broadened its alliance with AI specialist LynxKite to fast‑track longevity drug discovery, launching the MASSIVE project that seeks Mas receptor activators for sarcopenia. Backed by Enterprise Singapore, the partnership will augment Biophytis’ computational platform with LynxKite’s chemoinformatics, advanced...
Bayer Reports the P-III (FIND-CKD) Trial Data on Kerendia in Non-Diabetic Chronic Kidney Disease
Bayer disclosed results from the pivotal Phase III FIND‑CKD trial evaluating Kerendia (finerenone) in more than 1,500 adults with non‑diabetic chronic kidney disease. Patients received 10 mg or 20 mg of Kerendia alongside standard of care and were compared with placebo. The study...
Exploring Light and Life: Nanophotonics and AI for Molecular Sequencing and Single-Cell Phenotyping
Prof. Dionne introduced VINPix, a silicon‑photonic resonator platform with ultra‑high Q factors and sub‑wavelength mode volumes, capable of housing over 10 million devices per square centimeter. Coupled with acoustic bioprinting and artificial intelligence, the system promises simultaneous detection of genes, proteins,...
J&J Reports Positive Data for Erda-iDRS in Bladder Cancer
Johnson & Johnson announced encouraging Phase I data for its intravesical drug‑releasing system Erda‑iDRS in non‑muscle‑invasive bladder cancer (NMIBC) with FGFR alterations. The trial met its primary safety endpoint and delivered an 89% complete response rate in intermediate‑risk patients, with responses...
Spotlight Pathology Secures £1.4 Million Seed Investment for AI Blood Cancer Diagnostics
Liverpool‑based Spotlight Pathology has closed a £1.4 million seed round to accelerate its AI‑driven blood cancer diagnostic platform. The round was co‑led by the UK Innovation and Science Seed Fund and the Liverpool City Region Seed Fund, earmarked for product development,...
Roche Receives CE Mark for Its Elecsys ApoE4 Test to Support Blood-Based Alzheimer’s Biomarker Testing
Roche has secured CE Mark approval for its Elecsys ApoE4 in‑vitro diagnostic immunoassay, a blood‑based test that detects the ApoE4 gene variant linked to Alzheimer’s disease. In a validation study of 607 patients with cognitive complaints, the assay achieved 100%...
Effects of Mycoplasma Gallisepticum Infection on the Microbial Community Structure and Function in the Oviduct Magnum of Laying Hens
A preprint investigating Mycoplasma gallisepticum infection in Roman Gray laying hens reveals that infected birds host more operational taxonomic units (473 vs. 356) and a microbiome dominated by Mycoplasmatota. Alpha‑diversity metrics remained unchanged, but beta‑diversity analyses showed a highly significant community restructuring...
Graphene Oxide Quantum Dots Enable Biosensing of Depression Biomarkers
University of Delhi researchers have introduced an eco‑friendly method to synthesize graphene oxide quantum dots (GO QDs) using citric acid, producing uniform 23.4 nm particles with a negative surface charge. The GO QDs enable dual‑mode biosensing—optical fluorescence and electrochemical detection—of the...
Inter‐Crystal Spacing of Implantable Polymeric Surfaces as a Key Suppressor of Microbial Adhesion.
The researchers demonstrated that repeated shape‑memory polymer (SMP) recovery aligns surface crystals and compresses amorphous gaps, dramatically reducing bacterial adhesion. In vitro assays with Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus showed progressive detachment as programming cycles increased. An SMP...
Viatris Settles Lawsuit Over Use of Woman’s ‘Immortal’ Cells to Power Drug Research
Viatris agreed to dismiss the Henrietta Lacks estate lawsuit with prejudice, ending claims that the company used HeLa cells without permission in its herpes drug Denavir and depression treatment Mylan‑Mirtazapine. The settlement details were kept confidential. This resolution follows similar...
Denali’s Hunter Syndrome Candidate in the Spotlight After REGENXBIO Rejection
REGENXBIO's gene therapy RGX‑121 for Hunter syndrome received an FDA Complete Response Letter, with the agency flagging patient‑eligibility definitions, natural‑history control comparability, and the surrogate endpoint as problematic. The rejection redirects focus to Denali Therapeutics, whose enzyme‑replacement candidate tividenofusp alfa...
Vitamin B2 Pathway Identified as Potential Target for Cancer Therapy
A CRISPR‑Cas9 screen revealed that riboflavin (vitamin B2) sustains the ferroptosis suppressor protein FSP1, shielding cancer cells from iron‑driven lipid peroxidation. Depleting vitamin B2 destabilizes FSP1 and renders tumor cells highly susceptible to ferroptosis. The researchers demonstrated that roseoflavin, a bacterial analog...
Australia OKs Coin-Sized Sensor for Hydrocephalus Management
Australian regulators have approved M.scio, a coin‑sized, fully implanted intracranial pressure sensor developed by Germany’s Miethke and distributed by B. Braun. The Class III device provides continuous, telemetric ICP data for up to four years and is available in Flat and Dome...
Summit Midstream Corp (SMC) Q4 2025 Earnings Call Transcript
Summit Therapeutics reported a cash balance of $713 million and zero debt at year‑end, while GAAP operating expenses fell to $225 million. The FDA accepted its Biologics License Application for ivonesumab in EGFR‑mutant non‑small cell lung cancer, setting a PDUFA action date...
Singapore: AI, Genomics to Advance Precision Cancer Diagnostics
Singapore’s Agency for Science, Technology and Research has teamed with a precision‑oncology firm and the National Cancer Centre to launch UNITED 2.0, a SG$6 million three‑year project aimed at a clinical‑grade cancer profiling test. The new platform will replace the gene‑panel approach...
Hong Kong: Cross-Border Corridor to Drive Medical Innovation
The University of Hong Kong and Suzhou Industrial Park have signed a memorandum of understanding to launch the HKU‑Suzhou Innovation Corridor, a cross‑border platform for medical technology development. The corridor will link HKU’s research expertise with Suzhou’s clinical and biotech...
Monocyte Immune Shifts in HIV Patients on Injectable Therapy
Researchers published a longitudinal study showing that people living with HIV who switch from daily oral antiretrovirals to the long‑acting injectable combo cabotegravir‑rilpivirine experience an early, transient rise in monocyte activation followed by a sustained decline below baseline levels. Flow...
The Lethal Cost of Regulatory Perfection in Rare Disease
During a congressional hearing, neurologists warned that rare disease patients are dying while therapies linger in FDA review. The FDA recently rejected the SCA drug troriluzole, demanding more statistical certainty despite trial data showing over 50% fall‑risk reduction. Congress has...
Rethinking Where Patient Recruitment Begins
Clinical trials have long relied on site‑based recruitment, leaving under‑ and misdiagnosed patients underrepresented. Recent studies show digital outreach can identify symptomatic individuals who never enter traditional healthcare pathways, dramatically expanding the eligible pool. Digital campaigns have cut cost per...
New Planctomycete Species Discovered Underground
Researchers have isolated and described a new planctomycete, Anatilimnocola aquadivae sp. nov., from deep subsurface percolate samples. Comprehensive phenotypic, electron‑microscopic, and genomic analyses place it within the Pirellulaceae family but as a distinct lineage. The genome encodes anaerobic respiration, aromatic‑compound...
Aberrant mRNA Variants Drive Endometriosis Cell Growth
A recent study published in a leading gynecologic journal reveals that aberrant mRNA splice variants are a driving force behind the uncontrolled proliferation of endometriotic cells. Researchers identified a set of up‑regulated transcripts that activate the PI3K/AKT pathway, boosting lesion...
Transcutaneous CO2 Monitoring: The Future Standard of Care?
Transcutaneous carbon dioxide (tcCO₂) monitoring is emerging as a viable alternative to arterial blood gases and end‑tidal CO₂ in neonatal and pediatric intensive care. Recent Pediatric Research data show a strong correlation between tcCO₂ readings and PaCO₂ in stable patients,...
Techie Shrinks Dog's Tumor by Half After Using ChatGPT to Design ‘First Personalized Cancer Vaccine’
Australian tech enthusiast Paul Conyngham used ChatGPT and AlphaFold to design a personalized mRNA vaccine for his dog Rose, whose tumor was genetically sequenced at UNSW. The AI‑assisted workflow identified mutations and suggested therapeutic targets, enabling a custom vaccine administered...
Scientists Discover ALS Protein that Links DNA Repair to Cancer and Dementia
Researchers at Houston Methodist identified the ALS‑linked protein TDP43 as a regulator of DNA mismatch repair genes. Dysregulated TDP43—whether under‑ or over‑expressed—triggers abnormal repair activity that destabilizes the genome. Analysis of large cancer datasets revealed that tumors with high TDP43...
Japan Becomes First to Approve Stem Cell Therapies for Parkinson’s and Heart Failure
Japan has become the first country to grant conditional approval for two regenerative medicines that use induced pluripotent stem cells—AMCHEPRY for Parkinson’s disease and RiHEART for severe heart failure. The Parkinson’s therapy implants dopamine‑producing neurons into the brain, while the...
Q&A: Gassing up Bioengineered Materials for Wound Healing
Penn State researchers have engineered a new class of granular aerogel scaffolds (GAS) that allow precise control of pore architecture using protein‑based microparticles. The tunable, oxygen‑rich material demonstrated superior cell infiltration and rapid vascularization in both laboratory assays and mouse...
Re: Standard Chemoradiotherapy with Concurrent and Adjuvant Camrelizumab in Patients with High Risk Nasopharyngeal Carcinoma: Multicentre, Randomised, Open Label, Phase...
A phase‑3 BMJ trial reported that adding camrelizumab to standard chemoradiotherapy improved 36‑month progression‑free, distant‑metastasis‑free and locoregional‑recurrence‑free survival in high‑risk nasopharyngeal carcinoma. The protocol combined two concurrent cycles with 17 adjuvant cycles, yet only 61.9% of patients completed the full...
Zydus Lifesciences’ Anaemia Drug Desidustat Gets China Approval
Zydus Lifesciences has received NMPA approval for its oral anaemia drug Desidustat, targeting renal anaemia in adult chronic kidney disease patients who are not on dialysis. The therapy, a hypoxia‑inducible factor‑prolyl hydroxylase inhibitor, demonstrated efficacy and safety in Chinese Phase III...
A Lab Mistake at Cambridge Reveals a Powerful New Way to Modify Drug Molecules
Cambridge chemists have unveiled a light‑driven “anti‑Friedel‑Crafts” reaction that forms carbon‑carbon bonds using only LED illumination at ambient temperature. The metal‑free method allows precise, late‑stage modifications of complex drug molecules, cutting months of multistep synthesis. Tested on a broad set...
Immune Checkpoint Dysregulation Drives Pediatric Bronchiolitis Severity
A new multicenter study links dysregulated immune checkpoint pathways, especially PD‑1/PD‑L1 and CTLA‑4, to heightened severity in pediatric bronchiolitis. Researchers measured checkpoint molecule expression in airway samples from 312 infants and found that higher PD‑1 levels correlated with increased IL‑6,...
Pretzel Therapeutics Presents PX578 Data Supporting POLG Disease Treatment
Pretzel Therapeutics presented preclinical data for its investigational small‑molecule PX578 at the 2026 MDA Clinical and Scientific Conference. The drug is designed to activate the mitochondrial DNA polymerase gamma (POLG) and restore mitochondrial DNA levels in patients with mitochondrial DNA...
What’s New Pussycat? FDA Assists Drug Sponsors Requesting New Clinical Investigation Exclusivity
The FDA released draft Q&A guidance that clarifies how drug sponsors can qualify for three‑year non‑patent exclusivity by conducting a “new clinical investigation.” It defines a new study as a human, non‑bioavailability trial whose results have not been previously relied...
Rare Disease Spotlight: Friedreich Ataxia Moves Beyond Mitochondrial Bandages
Friedreich ataxia (FA) received its first FDA‑approved therapy in 2023 when omaveloxolone, marketed as Skyclarys, earned accelerated approval. Biogen’s $7.3 billion acquisition of Reata Pharmaceuticals secured the drug and highlighted the market’s appetite for rare‑disease assets. Skyclarys works by activating the...
Network-Based Prediction of Drug Combinations with Quantum Annealing
The study introduces a quantum‑annealing algorithm that predicts effective drug combinations by casting the problem as a quadratic unconstrained binary optimisation (QUBO). It leverages the network‑medicine concept of disease modules and the “Complementary Exposure” principle, which seeks drugs that hit...
Real-Time PCR–Based Detection of Mycoplasma Agalactiae in Sheep Bulk Tank Milk to Support Flock-Level Epidemiology
A real‑time PCR assay for detecting Mycoplasma agalactiae in sheep bulk‑tank milk was developed and validated, showing high specificity and sensitivity. The test was deployed across more than 900 dairy sheep farms in Sardinia, revealing widespread but generally low‑level prevalence...
Horse IVF Milestone in Florida: Frozen-Thawed Sperm Fertilizes an Egg
University of Florida researchers have achieved the first successful in‑vitro fertilization of a horse egg using frozen‑thawed sperm. The study showed that frozen‑thawed stallion sperm, after undergoing stress‑induced capacitation, fertilized the oocyte more effectively than fresh or chilled sperm. This...
Quantifying Pathway Identifiability Under Partial Metabolomics for Measurement Prioritization
The study introduces an operator‑based framework to assess pathway identifiability when metabolite coverage is incomplete. It aligns condition‑specific pathway graphs using a Johnson‑Lindenstrauss stabilized fused Gromov‑Wasserstein (JL‑FGW) operator and quantifies ambiguity via a composite functional that blends transport entropy, alignment...
Bacterial Strain Breaks Decades-Old Bottleneck in Chemotherapy Drug Manufacturing
An international research team has engineered a bacterial strain that boosts doxorubicin output by 180% compared with current industrial methods, overcoming three long‑standing bottlenecks—insufficient redox partners, drug‑binding “sponge” proteins, and suboptimal enzyme positioning. The findings, published in Nature Communications, detail...
Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits
During the COVID‑19 pandemic, vaccine makers pledged not to enforce mRNA‑related patents, but that restraint has ended, sparking a wave of litigation over lipid nanoparticle (LNP) and mRNA payload technologies. Major cases include Alnylam’s suits against Pfizer and BioNTech, Arbutus’s...
University of Calgary Researchers Use AI to Hunt New Treatments for Cattle Parasites
University of Calgary researchers have secured a $1.4 million NSERC grant to apply AI‑driven genomics in the hunt for new anti‑parasitic drugs targeting roundworms in beef cattle. By sequencing helminth genomes and screening large chemical libraries, the team has already identified...
Bimatoprost Implant Reduces IOP, Improves Vision at 12 Months
SpyGlass Pharma’s Bimatoprost Drug Pad‑IOL System demonstrated significant intra‑ocular pressure (IOP) reductions and vision gains in a phase 1/2 trial of 104 patients with open‑angle glaucoma or ocular hypertension undergoing cataract surgery. At 12 months, the 78 µg dose lowered mean IOP 34%...
FDA Approves Cosentyx for Pediatric Hidradenitis Suppurativa
The U.S. Food and Drug Administration has approved Novartis' secukinumab, marketed as Cosentyx, for adolescents aged 12 and older with moderate‑to‑severe hidradenitis suppurativa (HS). This marks the first IL‑17A inhibitor cleared for a pediatric indication, extending the drug’s adult HS...
Ultrasound-Based Approach to Delivering Potent Drugs Into Cancer Cells Shows Promise in Benchtop Experiments
Duke engineers introduced SonoPIN, an ultrasound‑driven platform that bursts cancer‑targeted microbubbles to create temporary pores in cell membranes. The technique allowed large PROTAC drugs to enter tumor cells, killing 50% of them while sparing 99% of healthy cells in benchtop...
